Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples.

Mugo NR, Heffron R, Donnell D, Wald A, Were EO, Rees H, Celum C, Kiarie JN, Cohen CR, Kayintekore K, Baeten JM; Partners in Prevention HSV/HIV Transmission Study Team..

AIDS. 2011 Sep 24;25(15):1887-95. doi: 10.1097/QAD.0b013e32834a9338.

2.

Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: prospective cohort study.

Humphrey JH, Marinda E, Mutasa K, Moulton LH, Iliff PJ, Ntozini R, Chidawanyika H, Nathoo KJ, Tavengwa N, Jenkins A, Piwoz EG, Van de Perre P, Ward BJ; ZVITAMBO study group..

BMJ. 2010 Dec 22;341:c6580. doi: 10.1136/bmj.c6580.

3.

What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs.

Mahy M, Stover J, Kiragu K, Hayashi C, Akwara P, Luo C, Stanecki K, Ekpini R, Shaffer N.

Sex Transm Infect. 2010 Dec;86 Suppl 2:ii48-55. doi: 10.1136/sti.2010.045989.

4.

Male antenatal attendance and HIV testing are associated with decreased infant HIV infection and increased HIV-free survival.

Aluisio A, Richardson BA, Bosire R, John-Stewart G, Mbori-Ngacha D, Farquhar C.

J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):76-82. doi: 10.1097/QAI.0b013e3181fdb4c4.

5.

The incidence of HIV among women recruited during late pregnancy and followed up for six years after childbirth in Zimbabwe.

Munjoma MW, Mhlanga FG, Mapingure MP, Kurewa EN, Mashavave GV, Chirenje MZ, Rusakaniko S, Stray-Pedersen B.

BMC Public Health. 2010 Nov 3;10:668. doi: 10.1186/1471-2458-10-668.

6.

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany AB, Sibeko S, Mlisana KP, Omar Z, Gengiah TN, Maarschalk S, Arulappan N, Mlotshwa M, Morris L, Taylor D; CAPRISA 004 Trial Group..

Science. 2010 Sep 3;329(5996):1168-74. doi: 10.1126/science.1193748. Erratum in: Science. 2011 Jul 29;333(6042):524.

7.

Coverage of nevirapine-based services to prevent mother-to-child HIV transmission in 4 African countries.

Stringer EM, Ekouevi DK, Coetzee D, Tih PM, Creek TL, Stinson K, Giganti MJ, Welty TK, Chintu N, Chi BH, Wilfert CM, Shaffer N, Dabis F, Stringer JS; PEARL Study Team..

JAMA. 2010 Jul 21;304(3):293-302. doi: 10.1001/jama.2010.990.

PMID:
20639563
8.

A decline in new HIV infections in South Africa: estimating HIV incidence from three national HIV surveys in 2002, 2005 and 2008.

Rehle TM, Hallett TB, Shisana O, Pillay-van Wyk V, Zuma K, Carrara H, Jooste S.

PLoS One. 2010 Jun 14;5(6):e11094. doi: 10.1371/journal.pone.0011094.

9.

Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.

Chasela CS, Hudgens MG, Jamieson DJ, Kayira D, Hosseinipour MC, Kourtis AP, Martinson F, Tegha G, Knight RJ, Ahmed YI, Kamwendo DD, Hoffman IF, Ellington SR, Kacheche Z, Soko A, Wiener JB, Fiscus SA, Kazembe P, Mofolo IA, Chigwenembe M, Sichali DS, van der Horst CM; BAN Study Group..

N Engl J Med. 2010 Jun 17;362(24):2271-81. doi: 10.1056/NEJMoa0911486.

10.

Estimating and Projecting Trends in HIV/AIDS Generalized Epidemics Using Incremental Mixture Importance Sampling.

Raftery AE, Bao L.

Biometrics. 2010 Dec;66(4):1162-73. doi: 10.1111/j.1541-0420.2010.01399.x.

11.

Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa.

Hoffman RM, Black V, Technau K, van der Merwe KJ, Currier J, Coovadia A, Chersich M.

J Acquir Immune Defic Syndr. 2010 May 1;54(1):35-41. doi: 10.1097/QAI.0b013e3181cf9979.

12.

Illness during pregnancy and bacterial vaginosis are associated with in-utero HIV-1 transmission.

Farquhar C, Mbori-Ngacha D, Overbaugh J, Wamalwa D, Harris J, Bosire R, John-Stewart G.

AIDS. 2010 Jan 2;24(1):153-5. doi: 10.1097/QAD.0b013e32832326d8.

13.

Male perspectives on incorporating men into antenatal HIV counseling and testing.

Katz DA, Kiarie JN, John-Stewart GC, Richardson BA, John FN, Farquhar C.

PLoS One. 2009 Nov 2;4(11):e7602. doi: 10.1371/journal.pone.0007602.

14.

Duration, pattern of breastfeeding and postnatal transmission of HIV: pooled analysis of individual data from West and South African cohorts.

Becquet R, Bland R, Leroy V, Rollins NC, Ekouevi DK, Coutsoudis A, Dabis F, Coovadia HM, Salamon R, Newell ML.

PLoS One. 2009 Oct 16;4(10):e7397. doi: 10.1371/journal.pone.0007397.

15.

Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.

Taha TE, Kumwenda J, Cole SR, Hoover DR, Kafulafula G, Fowler MG, Thigpen MC, Li Q, Kumwenda NI, Mofenson L.

J Infect Dis. 2009 Nov 15;200(10):1490-7. doi: 10.1086/644598.

16.

Breastfeeding with maternal antiretroviral therapy or formula feeding to prevent HIV postnatal mother-to-child transmission in Rwanda.

Peltier CA, Ndayisaba GF, Lepage P, van Griensven J, Leroy V, Pharm CO, Ndimubanzi PC, Courteille O, Arendt V.

AIDS. 2009 Nov 27;23(18):2415-23. doi: 10.1097/QAD.0b013e32832ec20d.

17.

A case series of 104 women infected with HIV-1 via blood transfusion postnatally: high rate of HIV-1 transmission to infants through breast-feeding.

Liang K, Gui X, Zhang YZ, Zhuang K, Meyers K, Ho DD.

J Infect Dis. 2009 Sep 1;200(5):682-6. doi: 10.1086/605123.

18.

Universal HIV testing of infants at immunization clinics: an acceptable and feasible approach for early infant diagnosis in high HIV prevalence settings.

Rollins N, Mzolo S, Moodley T, Esterhuizen T, van Rooyen H.

AIDS. 2009 Sep 10;23(14):1851-7. doi: 10.1097/QAD.0b013e32832d84fd.

PMID:
19491653
19.

Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine?

Foster C, Lyall H, Olmscheid B, Pearce G, Zhang S, Gibb DM.

HIV Med. 2009 Aug;10(7):397-406. doi: 10.1111/j.1468-1293.2009.00709.x. Review.

20.

High HIV incidence during pregnancy: compelling reason for repeat HIV testing.

Moodley D, Esterhuizen TM, Pather T, Chetty V, Ngaleka L.

AIDS. 2009 Jun 19;23(10):1255-9. doi: 10.1097/QAD.0b013e32832a5934.

PMID:
19455017
Items per page

Supplemental Content

Support Center